Search Result "NTRK fusion-positive tumors."
Entrectinib: A New Selective Tyrosine Kinase Inhibitor Approved forthe Treatment of Pediatric and Adult Patients with NTRK Fusionpositive,Recurrent or Advanced Solid Tumors
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 15 Year: 2022 Page: 2602-2616
Author(s): Meral Tuncbilek,Hind M. Osman
The ALK Gene, An Attractive Target for Inhibitor Development
Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 1406-1419
Author(s): Carmen J. Tartari, Leonardo Scapozza, Carlo Gambacorti-Passerini
Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy
Journal: Current Drug Targets
Volume: 17 Issue: 1 Year: 2016 Page: 1687-1703
Author(s): Mahdi Shabani, Mohammad Hojjat-Farsangi
Discovery of Tropomyosin Receptor Kinase Inhibitors as New GenerationAnticancer Agents: A Review
Journal: Current Topics in Medicinal Chemistry
Volume: 24 Issue: 1 Year: 2024 Page: 3-30
Author(s): Rati Kailash Prasad Tripathi
Growth Factors and Cancer
Ebook: Molecular Targets and Cancer Therapeutics (Part 1)
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815080384123010008
Computational Approaches for the Design of (Mutant-)Selective Tyrosine Kinase Inhibitors: State-of-the-Art and Future Prospects
Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 17 Year: 2020 Page: 1564-1575
Author(s): Prashant S. Kharkar
New Perspectives in Colorectal Cancers Treatment, the Role of MicroRNAs
Journal: Current Drug Targets
Volume: 25 Issue: 11 Year: 2024 Page: 715-723
Author(s): Liudmila V. Spirina,Victoria A. Belova,Alexandra V. Avgustinovich,Sergey G. Afanas'ev,Maxim Yu. Volkov,Daniil I. Azovsky,Alexander M. Volkov,Tatyana S. Klyushina
Genetic Alterations in Differentiated Thyroid Cancers
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9 Issue: 3 Year: 2009 Page: 257-268
Author(s): Behrouz Salehian, Zhong Liu, Fouad Kandeel
Advances in Drug Therapy for Gastrointestinal Stromal Tumour
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 21 Year: 2024 Page: 3057-3073
Author(s):
Pyrimidine-fused Dinitrogenous Penta-heterocycles as a Privileged Scaf-fold for Anti-Cancer Drug Discovery
Journal: Current Topics in Medicinal Chemistry
Volume: 22 Issue: 4 Year: 2022 Page: 284-304
Author(s):